Posted by: Northwest Eye in slt procedure on May 12, 2026
What SLT does for eye pressure
Selective laser trabeculoplasty, or SLT, uses laser energy on the eye’s drainage tissue to improve fluid drainage and lower eye pressure. It is mainly discussed for open-angle glaucoma and ocular hypertension, so an ophthalmologist first needs to understand your eye findings and glaucoma type.
During SLT, the laser selectively treats cells in the trabecular meshwork, the drainage tissue at the front of the eye. Untreated portions remain intact. A review describes SLT as using a very short 3 ns pulse and an energy level 1% of argon laser trabeculoplasty, or ALT, to target pigmented cells; that review says the treatment causes no histologic scarring or coagulative damage and can be repeated.
A review of 6,081 SLTs involving 4,601 eyes of 2,812 patients reported hyphema, or bleeding inside the front of the eye, in 12 eyes, or 0.2% of all SLTs. Measurable bleeding occurred in 4 eyes, or 0.07%, and corneal complications occurred in 6 eyes, or 0.1%; 4 of those eyes had high myopia. SLT is described as an option for open-angle disease.
The useful question is not simply whether a laser sounds appealing. It is whether SLT fits your drainage angle, pressure target, glaucoma findings, and broader treatment plan. The sections below explain what the evaluation and procedure involve, what you may notice afterward, and which questions can make an ophthalmology visit more useful.
Why glaucoma can be easy to miss
Glaucoma is a group of eye disorders that progressively damage the optic nerve and can lead to vision loss. The optic nerve carries visual information from your eye to your brain, so damage can affect sight even before you notice a clear change.
Open-angle glaucoma accounts for about 90 percent of all glaucoma cases. The drainage angle stays open, but the channels within it can become clogged over time. Because that process develops gradually, open-angle glaucoma typically causes no symptoms until moderate or advanced stages.
Your risk of primary open-angle glaucoma increases with age, a family history of glaucoma, type 2 diabetes, low blood pressure, hypothyroidism, obstructive sleep apnea, cardiovascular disease, or myopia. Having one of these factors does not establish a diagnosis, but it gives your eye doctor useful context for deciding how closely to evaluate you.
Gradual loss of side vision is often the first sign of glaucoma. Blurred vision, halos around lights, eye pain or pressure, and persistent red eyes may also indicate glaucoma or rising eye pressure. Do not rely on symptoms alone to decide whether your eyes need evaluation, because open-angle disease may remain unnoticed for a long time.
How an eye doctor determines the treatment path
Eye pressure typically ranges from 10 to 21 mmHg, measured in millimeters of mercury. A higher reading can raise concern, but no single pressure reading confirms glaucoma. Some people with high readings do not develop optic-nerve damage, while glaucoma can also occur with readings in the normal range.
A glaucoma evaluation may include several parts:
- Eye-pressure measurement: This shows the pressure at the time of testing, but it is only one part of the assessment.
- Gonioscopy: Your doctor examines the drainage angle to help distinguish open-angle and narrow-angle findings.
- OCT imaging: Optical coherence tomography creates detailed images that can show the optic nerve and nerve-fiber layer.
- Visual-field testing: This checks how well you see across different parts of your field of vision.
- Optic-nerve examination: Your doctor looks for changes in the optic nerve and other internal eye structures.
Evaluation may include a cup-to-disc ratio of 0.3 or greater, eye pressure greater than 21 mm Hg on tonometry, nerve-fiber-layer defects on optical coherence tomography, and reproducible visual-field defects. These findings are considered together rather than treated as a single pass-or-fail result.
Your ophthalmologist uses the examination to assess the optic nerve, drainage angle, pressure, cornea, and visual field. The results help determine whether monitoring, pressure-lowering drops, SLT, or another treatment should be discussed. Bring a list of your medicines and any changes in vision or eye symptoms to the visit.
Where SLT fits among glaucoma treatments
SLT may be a primary treatment option for some people with open-angle glaucoma. Prescription glaucoma drops remain a standard treatment option, and prostaglandin analogues are typically used once daily with established pressure-lowering efficacy. If SLT is not suitable or does not lower pressure enough, your ophthalmologist may discuss drops or glaucoma surgery based on your disease and treatment needs.
| Treatment path | What it involves | What to discuss |
|---|---|---|
| SLT | Laser energy is applied to drainage tissue to lower eye pressure. | Whether your drainage angle and glaucoma findings make it appropriate, and whether you may still need drops. |
| Pressure-lowering drops | Medication is used to lower eye pressure, with some medicines taken once daily. | Your dosing routine, response, side effects, and how long the treatment plan may continue. |
| Glaucoma surgery | Surgery may be considered when less invasive treatment is unsuitable or does not lower pressure enough. | The severity of your disease, surgical candidacy, expected follow-up, and other treatment choices. |
Guidance described in a recent review supports SLT as an initial or adjunctive option for some people with open-angle glaucoma or ocular hypertension, but appropriateness depends on the patient. In the LiGHT trial, target pressure was maintained during 93.0% of visits after initial SLT versus 91.3% after initial drops over 3 years. No patient in the initial-SLT group required incisional glaucoma surgery during that period, compared with 11 patients initially treated with drops.
Evidence is mixed. Early pressure lowering with SLT is generally comparable to glaucoma drops, but some studies report greater pressure lowering with prostaglandin drops. Some studies also report more nonresponders after SLT. Treatment choice still depends on your findings and preferences. You also need ongoing glaucoma monitoring after SLT to assess the pressure response and watch for disease progression.

What happens during the SLT procedure
SLT is usually done as an outpatient procedure, often in a doctor’s office. Numbing drops are placed in your eye, and your doctor places a special lens with gel on the eye to focus the laser on the drainage area. The lens also helps keep the eye still during treatment.
The visit generally follows this sequence:
- Your eye is numbed with drops.
- A focusing lens and clear gel are placed on the eye.
- Your doctor directs laser energy at cells in the trabecular meshwork.
- You hear a series of clicks and see bright flashes, similar to camera flashes.
- The lens is removed, and the gel is rinsed from the eye.
The laser treatment usually takes about 5–10 minutes. SLT is nearly painless, although you may feel slight tingling. The clicks and flashes can feel unusual, but they are expected parts of the treatment.
Some people need repeat treatment. In the LiGHT trial, 34.5% of the initial-SLT group received a second SLT and 9.5% received a third during 6 years of follow-up. Your prior response and ongoing pressure measurements help your ophthalmologist decide whether repeat treatment should be discussed.
What recovery and follow-up may involve
Your vision may be blurry briefly after SLT, especially while the contact-lens gel is rinsed away. Arrange transportation if your ophthalmologist expects temporary blur that could affect your ability to drive.
Use prescribed anti-inflammatory drops for a few days if your ophthalmologist gives them to you. Continue your regular glaucoma drops unless your ophthalmologist tells you otherwise. Do not change or stop glaucoma medicine on your own because the laser treatment does not automatically replace every medication.
Follow-up is important after SLT because your doctor needs to check the eye-pressure response and adjust the treatment plan if needed. The timing may be within a few weeks, with one patient guide describing follow-up typically 4–12 weeks after treatment. Keep that visit even if your vision feels unchanged.
SLT may take up to 2 months to reach its full effect. A pressure check before that point may not show the complete response, so follow the schedule your ophthalmologist gives you rather than judging the result from the first few days.

What benefits and limits to discuss
One ophthalmology patient source reports that SLT lowers eye pressure by about 20–30% on average and works for about 80% of patients. These figures describe that source’s reported average response and patient group; they do not predict your individual result. A review of randomized trials and meta-analyses found that early pressure lowering with SLT was generally comparable to glaucoma drops. However, some studies report greater pressure lowering with prostaglandin drops and more nonresponders after SLT.
One meta-analysis included 8 randomized controlled trials involving 1,229 patients. In that meta-analysis, the SLT and medication groups did not differ significantly in pressure reduction or successful pressure control. The SLT group used an average of 1.06 fewer medications. Other studies have reported greater pressure lowering with prostaglandin drops. The comparison describes study results, not a promise that you will reduce or stop drops.
SLT’s effect may wear off after several years, and repeat treatment may be possible depending on your prior response. You may still need glaucoma drops after SLT. The need varies with your glaucoma type and how quickly it is progressing.
In the LiGHT trial, 69.8% of eyes initially treated with SLT had adequate eye-pressure control without drops at 6 years, compared with 18% of eyes initially treated with medication. In the same trial, reported progression or glaucoma deterioration at 6 years was 19.6% after initial SLT and 26.8% after initial drops. Those results came from the United Kingdom trial population and should be discussed in the context of your own examination.
Ask how your target pressure was chosen, how long your doctor will wait before judging the response, and what the next step would be if the pressure stays above target. Also ask whether your glaucoma drops should continue, whether repeat SLT could be considered later, and which findings would make another treatment more suitable.
Common side effects and rare complications
Most side effects are mild and temporary, but SLT can cause a pressure spike, redness, blurred vision, discomfort, light sensitivity, or inflammation. In one study of 633 people who received SLT, 241 of 633 patients, or 38.1%, reported temporary blurred vision, discomfort, light sensitivity, or redness. Those symptoms typically resolved within several days.
A review reports that inflammation after SLT may appear within 2–3 days and generally resolves within 5 days. A temporary rise in eye pressure occurred after 1% of SLT treatments in the cited trial report. Your ophthalmologist may plan pressure monitoring or additional treatment based on your risk and examination.
High myopia and certain eye or glaucoma characteristics may raise the risk of complications, so your doctor should account for them when planning SLT. The cited review recommends careful patient selection, lower energy settings for predisposed patients, and unilateral treatment to reduce risks. Your ophthalmologist can explain whether careful patient selection, lower energy settings, or unilateral treatment applies to your eyes.
Reported complications include inflammation, pain, redness, a pressure spike, cystoid macular edema, bleeding, corneal edema, choroidal effusion, foveal burns, and refractive shifts. The cited review reported permanent vision loss in less than 1 in 4,600 treated eyes.
What SLT may cost
Published estimates for laser trabeculoplasty vary substantially. One listed estimate gives an average of $546, with a range of $425–$1,071. Another estimate places laser glaucoma procedures at $1,000–$2,000, in addition to possible anesthesia and operating-room fees.
The difference may reflect the procedure definition, pricing method, date, and which fees are included. Treat these figures as reference estimates rather than a procedure-specific quote for your visit.
More involved glaucoma surgeries average around $5,000 in one source, in addition to anesthesia costs and operating-room fees. Traditional trabeculectomy surgery is listed at about $4,200 in that source. Those figures describe more involved surgery, not the expected price of SLT.
Before treatment, request an itemized estimate that names the procedure, eye examination, facility charge, physician charge, anesthesia if applicable, medication, and follow-up. Ask your insurer what part of the care is covered and what you may owe. If the estimate uses a broad laser-surgery category, ask whether it applies specifically to SLT.
Questions to bring to an ophthalmology visit
Bring questions that connect your examination findings with the treatment plan. Your answers should help you understand whether SLT, drops, monitoring, or another procedure fits the pressure target and glaucoma findings your ophthalmologist identifies.
Primary open-angle glaucoma is the most common form of glaucoma in the United States. Up to one-half of patients with primary open-angle glaucoma are undiagnosed, partly because diagnosis may require monitoring over years. Lowering eye pressure is the only clearly validated, changeable treatment target in glaucoma management. SLT can help manage glaucoma by reducing eye pressure, but it does not cure glaucoma. Glaucoma procedures cannot restore lost vision, but they can help protect the sight that remains.
Guidance can differ by diagnosis and setting. A recent review describes 360-degree SLT as an initial treatment option for newly diagnosed ocular hypertension and early chronic open-angle glaucoma. The review reports that the European Glaucoma Society considers laser trabeculoplasty a possible first-line treatment for open-angle glaucoma or ocular hypertension. The American Academy of Ophthalmology describes laser trabeculoplasty as reasonable initially or as an adjunct in appropriate patients. The review also describes the Polish recommendation as more cautious than the explicit NICE recommendation. Having SLT does not prevent later glaucoma medicines or procedures if they are needed.
Angle-closure glaucoma follows a different treatment path. Pupil block is its most common cause, and an acute attack requires same-day referral to an ophthalmologist. Guidance for acute angle closure describes medication and laser treatment; a YAG laser may create a tiny opening in the iris to help fluid drain, and later surgery may be recommended. Angle-closure glaucoma can damage the nerve cells that carry visual information from the eye. Drugs may be used as first aid before specialist treatment. Acute angle closure can cause sudden blurred vision, a red eye, pain, headache, and nausea or vomiting. The sudden rise in eye pressure can quickly damage the optic nerve. This path differs from the drainage-tissue approach used by SLT.
Use this checklist:
- What type of glaucoma or pressure problem do I have, and is my drainage angle open?
- What is my target eye pressure, and which examination findings set that target?
- What did my optic-nerve examination, OCT, visual-field test, and pressure measurement show?
- Is SLT an initial option, an additional treatment, or not a suitable option for my findings?
- How does SLT compare with once-daily pressure-lowering drops for my treatment needs?
- If SLT does not lower pressure enough, what would you discuss next?
- Should I continue my current glaucoma drops before and after treatment?
- When will you check my pressure after SLT, and how will you judge the response?
- Could I need repeat SLT later, and what would guide that decision?
- Which symptoms after treatment should prompt a call or urgent evaluation?
Ask whether the estimate applies specifically to SLT.
When sudden eye changes need immediate care
Seek immediate medical attention for sudden severe eye pain, a red eye, nausea, headache, blurred vision, or halos around lights. Get immediate evaluation for sudden vision loss, rainbow-colored halos with other vision problems, nausea or vomiting with eye symptoms, or a severe headache with eye pain.
If eye pain, headache, redness, and nausea occur together, contact a provider or go to an emergency room because immediate treatment may be needed to protect your vision. Seek emergency care right away for sudden, severe eye pain or pressure because acute angle-closure glaucoma can cause permanent vision loss in just a few hours.
Do not wait for every symptom to appear before seeking care. Do not change glaucoma treatment yourself while waiting for an appointment. Sudden symptoms need immediate qualified evaluation rather than a routine discussion about whether SLT might be appropriate.
Take the next step toward a treatment discussion
SLT can lower eye pressure for some people with open-angle disease, but the decision depends on your drainage angle, optic nerve, pressure target, glaucoma type, treatment history, and follow-up needs. An ophthalmologist should decide whether SLT fits your findings and whether drops or another treatment belongs in the plan. Bring the checklist above and request an itemized estimate so you can compare the options clearly.
An eye exam at Northwest Eye in Minnetonka can give you time to review your glaucoma evaluation, discuss treatment choices, and plan the follow-up your eyes need.
Practical questions about SLT
How does an eye doctor decide whether SLT is appropriate?
An ophthalmologist considers your drainage angle, glaucoma type, optic-nerve findings, eye pressure, visual field, corneal thickness, and treatment history. SLT may not suit everyone, including people with active eye inflammation, neovascular glaucoma, or an opacity that blocks a clear view of the drainage tissue. Ongoing monitoring remains necessary.
What should I do if I develop sudden eye pain or vision changes?
Seek immediate medical attention for sudden severe eye pain, a red eye, blurred vision, halos, headache, nausea, vomiting, or sudden vision loss. Do not wait for every symptom to appear or change glaucoma medicine yourself. These symptoms can signal an urgent pressure problem that needs qualified evaluation.
What does SLT typically cost, and what changes the price?
Published estimates vary by procedure definition, date, and included fees. One listing gives laser trabeculoplasty an average cost of $546, with a range of $425 to $1,071; another estimates laser glaucoma procedures at $1,000 to $2,000. Ask for an itemized, procedure-specific estimate covering facility, physician, medication, and follow-up charges.





